Encapsulating Peritoneal Sclerosis In a Kidney Graft Recipient Unmasked by Everolimus Switch.
作者信息
Pozdzik Agnieszka A, Fernandez Vasco, Demetter Pieter, Tooulou Monika, Matos Celso, Gammar Nadia, Broeders Nilufer, Dratwa Max, Nortier Joëlle
机构信息
Department of Nephrology, Dialysis and Renal Transplantation, Clinique Universitaire de Bruxelles (CUB), Erasme Hospital, Université Libre de Bruxelles (ULB) Brussels, Belgium
Department of Nephrology, Cury Cabral Hospital, Lisbon, Portugal.
出版信息
Perit Dial Int. 2015 Dec;35(7):769-71. doi: 10.3747/pdi.2014.00157.
Abstract
摘要
相似文献
1
Encapsulating Peritoneal Sclerosis In a Kidney Graft Recipient Unmasked by Everolimus Switch.
Perit Dial Int. 2015 Dec;35(7):769-71. doi: 10.3747/pdi.2014.00157.
2
Encapsulating peritoneal sclerosis: common or rare in peritoneal dialysis?
Saudi J Kidney Dis Transpl. 2013 Mar;24(2):223-9. doi: 10.4103/1319-2442.109562.
3
Encapsulating peritoneal sclerosis--a complication of peritoneal dialysis.
N Z Med J. 2011 Sep 9;124(1342):89-93.
4
Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis - Position Paper for ISPD: 2017 Update.
Perit Dial Int. 2017 Jul-Aug;37(4):362-374. doi: 10.3747/pdi.2017.00018.
5
Encapsulating peritoneal sclerosis.
Pol Arch Med Wewn. 2013;123(3):125-6.
6
Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD.
Perit Dial Int. 2009 Nov-Dec;29(6):595-600.
7
Long-Term Success with Adhesiolysis in Post-Transplant Encapsulating Peritoneal Sclerosis: A Retrospective Case Series of 4 Patients and Review of the Literature.
Intern Med. 2016;55(3):269-72. doi: 10.2169/internalmedicine.55.5461. Epub 2016 Feb 1.
8
Encapsulating peritoneal sclerosis: from early diagnosis to successful kidney transplantation.
J Bras Nefrol. 2022 Oct-Dec;44(4):587-591. doi: 10.1590/2175-8239-JBN-2021-0001.
9
mTOR inhibitors for management of encapsulating peritoneal sclerosis: a review of literatures.
Ren Fail. 2016 Nov;38(10):1574-1580. doi: 10.1080/0886022X.2016.1209026. Epub 2016 Jul 17.
10
mTOR inhibitors for medical treatment of post-transplantation encapsulating peritoneal sclerosis: a favourable single center experience.
J Nephrol. 2015 Apr;28(2):245-9. doi: 10.1007/s40620-014-0168-7. Epub 2015 Jan 14.
本文引用的文献
1
Everolimus-induced lymphedema in a renal transplant recipient: a case report.
Exp Clin Transplant. 2012 Jun;10(3):296-8. doi: 10.6002/ect.2011.0139.
2
Initial observations using a novel "cine" magnetic resonance imaging technique to detect changes in abdominal motion caused by encapsulating peritoneal sclerosis.
Perit Dial Int. 2011 May-Jun;31(3):287-90. doi: 10.3747/pdi.2010.00078. Epub 2011 Mar 31.
3
Posttransplantation encapsulating peritoneal sclerosis contributes significantly to mortality after kidney transplantation.
Am J Transplant. 2011 Mar;11(3):599-605. doi: 10.1111/j.1600-6143.2010.03434.x. Epub 2011 Feb 7.
4
Development of encapsulating peritoneal sclerosis in a renal transplant recipient on sirolimus immunotherapy.
Perit Dial Int. 2010 Jul-Aug;30(4):475-7. doi: 10.3747/pdi.2009.00211.
5
Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes.
Kidney Int. 2010 May;77(10):904-12. doi: 10.1038/ki.2010.16. Epub 2010 Mar 10.
6
Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.
Adv Perit Dial. 2008;24:104-10.
7
Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.
Kidney Int. 2007 Apr;71(8):771-7. doi: 10.1038/sj.ki.5002112. Epub 2007 Feb 14.
Zotero 插件